Zetia Buyers Get Narrow Market In Generic-Delay Suit

By Matthew Perlman · February 25, 2022, 7:23 PM EST

A Virginia federal court has sided with buyers in their bid to limit the scope of competition considered in their suit accusing Merck and Glenmark of striking a deal to keep...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

In Re: Zetia (Ezetimibe) Antitrust Litigation

Case Number

Court

Virginia Eastern

Nature of Suit

Anti-Trust

Date Filed

June 15, 2018

Recent Articles By Matthew

August 16, 2024
Calif. State Court Tosses Antitrust Case Against MultiPlan
August 16, 2024
5th Circ. Tosses Appeal In FTC's Anesthesia Antitrust Case
August 13, 2024
Anesthesia Co. Says FTC Lacks Authority To Bring 'Rollup' Suit
August 12, 2024
States Oppose Shkreli High Court Bid For $64M Disgorgement
August 07, 2024
Delta Dental Can't Get Antitrust Standard Decided Early
August 01, 2024
AliveCor Asks 9th Circ. To Revive Apple Watch Antitrust Case
July 19, 2024
Boehringer Looks To Toss Inhaler Antitrust Case
July 17, 2024
Boehringer Wants Inhaler Antitrust Case Moved To Mass.
July 10, 2024
Buyers Say Teva Had Multipart Scheme To Delay Inhaler Rivals
July 09, 2024
FTC Says Drug Middlemen Inflate Costs, Squeeze Pharmacies